Human Menopausal Gonadotropin versus Recombinant FSH in Polycystic Ovary Syndrome Patients Undergoing In Vitro Fertilization

BACKGROUND: We aimed to compare human menopausal gonadotropin (hMG) and recombinant follicle-stimulating hormone (r FSH) with respect to clinical outcomes and the development of ovarian hyperstimulation syndrome (OHSS) for patients with polycystic ovary syndrome (PCOS) treated with in vitro fertiliz...

Descripción completa

Detalles Bibliográficos
Autores principales: Figen Turkcapar, Ayse, Seckin, Berna, Onalan, Gogsen, Ozdener, Tulin, Batioglu, Sertac
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royan Institute 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850313/
https://www.ncbi.nlm.nih.gov/pubmed/24520446

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850313/
https://www.ncbi.nlm.nih.gov/pubmed/24520446

Ejemplares similares